[vc_row][vc_column width=”1/1″]

[vc_column_text]Chris Kofinis of Park Street Strategies visited CNBC to share his opinion on how Heather Bresch, CEO of Mylan, should handle her recent crisis – the high price increase of Mylan’s EpiPen drug and the pay boost Bresch received in light of it.

Click here to subscribe to our YouTube channel to stay up-to-date with latest news and industry insights.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][vc_raw_html]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[/vc_raw_html][/vc_column][/vc_row]